Could cause temporary or reversible harm; serious harm is unlikely.
Lack of Assurance of Sterility
| Brand name | DEXTROSE |
| Generic name | DEXTROSE MONOHYDRATE |
| Active ingredient(s) | DEXTROSE MONOHYDRATE |
| Distributed by / for | Fresenius Kabi USA, LLC |
| NDC | 65219-456-05 |
| Full product label | 5% Dextrose Injection, USP 2.5 g per 50 mL (50 mg per mL) 50 mL in a 100 mL freeflex bag, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Use NDC: 65219-456-05, Unit of Sale NDC Number: 65219-456-60. |
| Recalling firm | Fresenius Kabi USA, LLC |
| Distribution | US Nationwide , Alaska, and Puerto Rico. |
| Recall initiated | 2026-03-11 |
| Report date | 2026-04-15 |
| Recall completed | — |
| Recall number | D-0435-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Lake Zurich IL United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗